Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Angiomax_Monotherapy_Associated_with_Reduced_Net_Adverse_Clinical_Events,_Major_Bleeding_and_Cardiac‐Related_Death_Compared_to_Heparin_Plus_a_Glycoprotein_IIb/IIIa_Inhibition_in_Primary_PCI:_Results_of_HORIZONS_AMI&oldid=532334"